Updated Mar. 3, 2014 at 5:47 a.m.

Premium Lock Scynexis files for $55M IPO, banks on antifungal returned by Merck

Published: 2014-02-28 09:47:00
Updated: 2014-03-03 05:47:53

The Scynexis pipeline The Scynexis pipeline, from the Scynexis website Image 1 of 2 · Next Image…

Scynexis originally partnered with drug giant Merck in 2002 to develop and commercialize a compound called SCY-078. Merck chose to return it last year. Now, Scynexis sees the compound as key to helping it pull off a public offering of stock. It is targeting a $3.6 billion market. So what makes the compound so special?...

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders